What are the chances of IVF working first time?

Written in association with: Dr Benjamin Abramov
Published: | Updated: 01/02/2019
Edited by: Cal Murphy

For couples struggling to have a baby due to infertility, in vitro fertilisation (IVF) is an option many look to. While it raises the couple’s chance of conceiving, there is no guarantee that it will successfully result in the birth of a baby. So, what exactly are the chances of IVF working first time, and why do treatment cycles fail? Leading fertility specialist Dr Benjamin Abramov is here to explain.

What is the chance of a single in vitro fertilisation (IVF) treatment cycle resulting in a birth of a baby? 

IVF success rates are age-related. Figures were obtained from cycles carried out across the USA in 2010, which suggested that the chances of having a baby from a single IVF treatment cycle in women of different ages were as follows:

  • < 35 – approximately 40%.
  • 36-38 – approximately 30%
  • 38-40 – approximately 20%.
  • 40-42 – only 10% of cycles ended with a baby.
  • 42-44 – 5% of cycles ending with a live birth.

At the age of 45 any given treatment cycle had only 1% chance in resulting in a birth of a baby. 

 

Why do so many IVF treatment cycles fail? 

Unlike men, who produce sperm throughout their lifetime (and therefore may only expect a moderate age-related drop in their fertility), women are born with a fixed reservoir of their eggs. This reservoir is subject to two processes which affect the chances of pregnancy.

Firstly, the number of eggs in this reservoir depletes constantly from birth onwards. This decline in the number of eggs is not hormone-dependent and is not affected by pregnancies, fertility treatment or by the use of oral contraceptive pills. In fact, the most significant drop in this reservoir of eggs occurs between birth, when a baby girl is estimated to have around 2 million eggs, and puberty, when the estimated number is around 300,000-500,000.

The second process that affects eggs is that they age throughout a women’s reproductive life span. This aging process makes the eggs more likely to produce an embryo with an abnormal makeup of chromosomes.

Both these processes – the decline in the number of eggs and the drop in their chromosomal quality through ageing – seems to speed up for women in their mid-thirties and onwards.

IVF treatment depends heavily on both the number of eggs that the doctors manage to mature and retrieve by the use of fertility drugs (with 10-15 eggs regarded as the optimal number) and on the quality of the eggs retrieved.

A significant proportion of all embryos produced during IVF treatment carry an abnormal makeup of chromosomes. Such embryos will not implant, or may implant but then result in a miscarriage. Occasionally, such embryos result in an ongoing pregnancy with a prenatal diagnosis of anomalies leading to a termination or the birth of a child with a serious disability. Pre-implantation genetic screening (PGS) can be used to examine the chromosomes of the embryos and determine which are viable for implantation.

 

 

The best chances of success

The younger a woman is, the more likely it is that a higher majority of her embryos will have a normal makeup of chromosomes. Additionally, when a woman has a good reservoir of eggs, the fertility specialists are more likely to retrieve a good number of eggs in an IVF treatment cycle and subsequently, they are more likely to end with a higher number of embryos. A higher number of embryos created translates into a better chance that at least one of them will have a normal makeup of chromosomes to allow a live birth of a healthy child. 

By Dr Benjamin Abramov
Fertility specialist

Dr Benjamin Abramov is a renowned fertility specialist and gynaecologist based in London. He focuses principally on pre-implantation genetic screening (PGS) and pre-implantation genetic diagnosis (PGD), IVF, and the management of recurrent miscarriages
 
Dr Abramov has been a pioneering figure in assisted conception since earning his MD in 1994. Throughout his career, he has held key positions in various fertility treatment centres, consistently pushing the boundaries of reproductive science.
 
Having completed his medical degree during a crucial period in reproductive medicine, particularly with the emergence of ICSI for male factor infertility, Dr Abramov developed a keen interest in pre-implantation genetic testing. His focus lies in understanding its profound implications for patients facing recurrent miscarriage or hereditary genetic conditions.
 
Dr Abramov is known for his innovative approach within his fertility clinic, continuously seeking new solutions and striving for enhanced patient outcomes. He has been instrumental in pioneering several treatment protocols and approaches, which have now become standard practices for addressing issues like unexplained infertility, male factor infertility, and recurrent miscarriage.
 
Central to Dr Abramov's philosophy is his unwavering commitment to treating each patient with profound empathy and respect. He meticulously considers their medical history, lifestyle factors, and overall gynaecological health to tailor bespoke treatment plans aimed at optimising every cycle and maximising success rates and his devotion lies in being a beacon of hope amidst the challenges. Dr Abramov understands the arduous journey patients face. While acknowledging the uncertainties inherent in fertility treatment, his dedication remains unwavering, leaving no stone unturned in pursuit of the best possible outcomes for his patients.

View Profile

Overall assessment of their patients


  • Related procedures
  • Laparoscopy
    Menopause
    Preparation for childbirth
    Amniocentesis
    Ovarian cyst
    Polycystic ovary syndrome (PCOS)
    Endometrial polyps
    Uterine malformations
    Medicine playback
    Fertility test
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.